Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New registry aims to uncover hidden risks for pregnant women with heart disease

NCT ID NCT04828070

Knowledge-focused Sponsor: Saint Luke's Health System Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This registry follows 75 pregnant women with heart disease to better understand the risks and outcomes for both mother and baby. Researchers will track health data for one year and check vital status at five years. The goal is to fill knowledge gaps and improve future care for this group.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this registry could provide crucial data to guide better care and reduce risks for pregnant women with heart disease.
What could go wrong
This is an observational registry, not a treatment trial. It will not directly improve outcomes and may face challenges in collecting complete data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 75 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2020

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women with cardiovascular disease

Ages

18 to 55 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 and older * Pregnant at any point in gestation (with singleton or multiple gestation) * History of congenital and/or acquired heart disease defined as the following: * valvular, congenital, ischemic heart disease or cardiomyopathy, * clinically significant maternal arrhythmias in women, * current or previous history of peripartum cardiomyopathy, * supraventricular tachycardia, * placement of either a pacemaker or electrical assist device, * aortopathies (Marfan syndrome, Loey's Deitz, Ehlers Danlos \[vascular subtype\], * pre-pregnancy diagnosis of pulmonary hypertension * English- or Spanish-speaking Exclusion Criteria: * Unable to provide written informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart disorder pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac disease Pregnancy related

Contacts and locations

Locations

  • Saint Luke's Hospital of Kansas City

    Kansas City, Missouri, 64111, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.